Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.
Int J Cancer. 2019 Oct 1;145(7):1782-1797. doi: 10.1002/ijc.32385. Epub 2019 May 20.
Int J Cancer. 2019.
PMID: 31050813
Free article.